Hye Ri Ahn

582 total citations · 1 hit paper
16 papers, 409 citations indexed

About

Hye Ri Ahn is a scholar working on Cancer Research, Molecular Biology and Hepatology. According to data from OpenAlex, Hye Ri Ahn has authored 16 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 9 papers in Molecular Biology and 4 papers in Hepatology. Recurrent topics in Hye Ri Ahn's work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and Extracellular vesicles in disease (4 papers). Hye Ri Ahn is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers) and Extracellular vesicles in disease (4 papers). Hye Ri Ahn collaborates with scholars based in South Korea. Hye Ri Ahn's co-authors include Jae Youn Cheong, Soon Sun Kim, Hyo Jung Cho, Jung Woo Eun, Geum Ok Baek, Suk Woo Nam, Jung Hwan Yoon, Sung Won Cho, Tae Wook Kang and Won Park and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Cell Death and Disease.

In The Last Decade

Hye Ri Ahn

16 papers receiving 406 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib

2023 104 citations Jung Woo Eun, Jung Hwan Yoon et al. Cancer Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hye Ri Ahn South Korea	11	232	214	113	85	71	16	409
Geum Ok Baek South Korea	11	321 1.4×	304 1.4×	95 0.8×	90 1.1×	72 1.0×	18	468
Dinglan Zuo China	14	249 1.1×	193 0.9×	187 1.7×	90 1.1×	100 1.4×	25	534
Zu-Shun Chen China	7	112 0.5×	185 0.9×	128 1.1×	64 0.8×	165 2.3×	10	356
Wenli Sai China	12	202 0.9×	151 0.7×	90 0.8×	48 0.6×	107 1.5×	32	366
Keshuai Dong China	14	193 0.8×	133 0.6×	102 0.9×	54 0.6×	131 1.8×	26	418
Yunxing Shi China	10	178 0.8×	123 0.6×	145 1.3×	82 1.0×	68 1.0×	17	386
Boyi Liao China	11	325 1.4×	286 1.3×	81 0.7×	43 0.5×	67 0.9×	13	504
Xi Ai China	10	163 0.7×	80 0.4×	101 0.9×	40 0.5×	90 1.3×	24	361
Chen-Yu Hu China	12	214 0.9×	126 0.6×	43 0.4×	41 0.5×	85 1.2×	19	371

Countries citing papers authored by Hye Ri Ahn

Since Specialization

Citations

This map shows the geographic impact of Hye Ri Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hye Ri Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hye Ri Ahn more than expected).

Fields of papers citing papers by Hye Ri Ahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hye Ri Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hye Ri Ahn. The network helps show where Hye Ri Ahn may publish in the future.

Co-authorship network of co-authors of Hye Ri Ahn

This figure shows the co-authorship network connecting the top 25 collaborators of Hye Ri Ahn. A scholar is included among the top collaborators of Hye Ri Ahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hye Ri Ahn. Hye Ri Ahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Ahn, Hye Ri, Sujin Kim, Geum Ok Baek, et al.. (2024). Effect of Sortilin1 on promoting angiogenesis and systemic metastasis in hepatocellular carcinoma via the Notch signaling pathway and CD133. Cell Death and Disease. 15(8). 634–634. 7 indexed citations

Eun, Jung Woo, Jung Hwan Yoon, Hye Ri Ahn, et al.. (2023). Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib. Cancer Communications. 43(4). 455–479. 104 indexed citations breakdown →

Eun, Jung Woo, Hye Ri Ahn, Geum Ok Baek, et al.. (2023). Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 24(5). 4272–4272. 7 indexed citations

Baek, Geum Ok, Hye Ri Ahn, Hyo Jung Cho, et al.. (2023). Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 42(1). 288–288. 9 indexed citations

Ahn, Hye Ri, Geum Ok Baek, Jung Hwan Yoon, et al.. (2022). Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 41(1). 158–158. 11 indexed citations

Ahn, Hye Ri, Geum Ok Baek, Jung Hwan Yoon, et al.. (2022). Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma. Cancers. 14(4). 865–865. 17 indexed citations

Kim, Soon Sun, Geum Ok Baek, Hye Ri Ahn, et al.. (2021). Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle‐derived long noncoding RNAs identified as markers. Molecular Oncology. 15(10). 2715–2731. 32 indexed citations

Ahn, Hye Ri, et al.. (2021). Comparative effectiveness and safety of growth hormone monotherapy and combination therapy with herbal medicine and growth hormone in short stature children. 2(5). e0104–e0104. 1 indexed citations

Cho, Hyo Jung, Geum Ok Baek, Hye Ri Ahn, et al.. (2021). Overexpressed Proteins in HCC Cell-Derived Exosomes, CCT8, and Cofilin-1 Are Potential Biomarkers for Patients with HCC. Diagnostics. 11(7). 1221–1221. 12 indexed citations

10.

Ahn, Hye Ri, Ji Hyun Song, & Hye Lim Lee. (2020). A Review of the Experimental Studies on the Modulatory Effect Herbal Medicine on Gut Microbiota. The Journal of Pediatrics of Korean Medicine. 34(4). 43–58. 2 indexed citations

11.

Cho, Hyo Jung, Bohyun Kim, Hye Jin Kim, et al.. (2020). Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment. European Radiology. 30(8). 4182–4192. 44 indexed citations

12.

Kim, Bohyun, Soon Sun Kim, Sung Won Cho, et al.. (2020). Liver stiffness in magnetic resonance elastography is prognostic for sorafenib-treated advanced hepatocellular carcinoma. European Radiology. 31(4). 2507–2517. 13 indexed citations

13.

Kim, Soon Sun, Geum Ok Baek, Hye Ri Ahn, et al.. (2020). Serum small extracellular vesicle‐derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma. Molecular Oncology. 14(10). 2646–2659. 59 indexed citations

14.

Eun, Jung Woo, Geum Ok Baek, Hye Ri Ahn, et al.. (2020). Circulating Exosomal MicroRNA-1307-5p as a Predictor for Metastasis in Patients with Hepatocellular Carcinoma. Cancers. 12(12). 3819–3819. 19 indexed citations

15.

Kim, Soon Sun, Jung Woo Eun, Ji Hye Choi, et al.. (2020). MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma. Scientific Reports. 10(1). 17862–17862. 23 indexed citations

16.

Cho, Hyo Jung, Geum Ok Baek, Hye Ri Ahn, et al.. (2020). Exosomal microRNA‐4661‐5p–based serum panel as a potential diagnostic biomarker for early‐stage hepatocellular carcinoma. Cancer Medicine. 9(15). 5459–5472. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact